Insights into CytoSorbents's Upcoming Earnings

CytoSorbents (NASDAQ:CTSO) is set to give its latest quarterly earnings report on Monday, 2025-03-31. Here's what investors need to know before the announcement.

Analysts estimate that CytoSorbents will report an earnings per share (EPS) of $-0.07.

Investors in CytoSorbents are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.02, leading to a 18.05% drop in the share price the following trading session.

Here's a look at CytoSorbents's past performance and the resulting price change:

Quarter

Q3 2024

Q2 2024

Q1 2024

Q4 2023

EPS Estimate

-0.06

-0.09

-0.12

-0.14

EPS Actual

-0.04

-0.08

-0.12

-0.12

Price Change %

-18.0%

8.0%

12.0%

-9.0%

CytoSorbents Share Price Analysis

Shares of CytoSorbents were trading at $1.0 as of March 27. Over the last 52-week period, shares are up 9.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Insights on CytoSorbents

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on CytoSorbents.

Analysts have given CytoSorbents a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $10.0, indicating a potential 900.0% upside.

Peer Ratings Comparison

The below ...